|
|
|
|
|
|
|
|
Take a tour of Nanoform's best-in-class nanodevelopment capabilities, setting new standards in innovation. Their highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. With 14 development lines for small molecules and 5 for large molecules, Nanoform offers unmatched scalability and precision. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers. Learn more
|
|
|
|
|
|
|
|
By Drug Delivery Leader: Supplier Horizons
|
Stephen Stein, scientific director of inhalation products at Kindeva, joins Supplier Horizons host Tom von Gunden in a videocast discussion of opportunities and challenges for inhalation product development.
|
|
|
|
|
|
Subcutaneous Self-Administration: Market Drivers And Delivery Challenges
|
|
By Fran DeGrazio, executive editor, Drug Delivery Leader
|
In this article, Fran DeGrazio comments on the potential for subcutaneous delivery of drugs and biologics to advance and ease approaches to patient self-administration. Among the drivers and challenges she identifies are geriatric populations, chronic conditions, complex formulations, and drug delivery device selection.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Spray Drying To Enhance High Lipophilic Drug Solubility
|
|
White Paper | By Anthony Qu, Adare Pharma Solutions
|
A new R&D project shows the solubility and dissolution characteristics of Itraconazole can be improved by helping them maintain an amorphous state after spray drying with selected hydrophilic polymers.
|
|
|
|
|
|
Modeling Tools For Small Molecule Solid Dose Production
|
|
White Paper | By Christin Hollis, Ph.D., and Rohit Ramachandran, Ph.D.
|
Data-driven modeling techniques can enhance scale-up processes, streamline production, and help companies navigate the complexities of modern drug development with greater precision and reliability.
|
|
|
|
|
|
Optimizing Safe Delivery With A Focus On Finished Goods
|
|
Article | By Lenette Simonsen, Behrouz Seifi, and Morten Lahrmann, FUJIFILM Biotechnologies
|
As demand forecasts evolve, opt to work with a CDMO that can pivot manufacturing strategies seamlessly while accommodating your end-to-end needs, from drug substance to finished goods.
|
|
|
|
|
|
|
|
|
|
|
The PDA Pharmaceutical Microbiology Conference 2025 marks two decades of advancing microbiological science and practice. This milestone event brings together the global microbiology community, including experts from industry, academia, and regulatory agencies, to explore the evolving landscape of pharmaceutical microbiology. This year’s theme, Microbial Resilience: Today’s Response, Tomorrow’s Plan, reflects our focus on navigating present-day challenges while building robust strategies for the future.
|
|
|
|
|
|
|
|
|
|
|
.png){kind=logo}
